Corcept is a leader in cortisol modulation, developing selective glucocorticoid receptor (GR) antagonists to treat serious diseases. With over 25 years of research, including the FDA-approved treatment for Cushing’s syndrome, Corcept is pioneering advancements in oncology, endocrine, and metabolic disorders through global partnerships and innovative therapies.
Corcept Therapeutics Highlights:
Overview
- Website: corcept.com
- Headquarters: Redwood City, California
- Employees: 470
- Founded: 1998
- Email: info@corcept.com
- Funding: $722.2B
- Revenue: $569.6M
- Valuation: n/a
Contacts
- Email: ***@corcept.com
Similar companies
Frequently Asked Questions related to Corcept Therapeutics
Corcept Therapeutics is located in Redwood City, California.
Yes, Corcept Therapeutics is a Silicon Valley company.
Corcept Therapeutics total funding is 722.2B.
Corcept Therapeutics revenue is 569.6M.
Corcept Therapeutics’s number of employees is 470.
Corcept Therapeutics’s CEO name is Atabak Mokari.
Corcept Therapeutics was founded in 1998.
Corcept Therapeutics’s contact email is info@corcept.com.
